NSE/ZYDUSLIFE (NSE/ZYDUSLIFE)

National Stock Exchange of India: NSE/ZYDUSLIFE · INR

₹1,176

+2.58 (+0.2%)· Recorded snapshot

Market cap	1.2T
Revenue (ttm)	285.9B
Net income (ttm)	45.1B
EPS (ttm)	₹44.9
Shares out	997.5M
P/E (trailing)	26.2x
P/E (forward)	27.5x
Dividend	₹1.00 (0.09%)
Volume	596,781
Beta	0.37

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 285.9B
Net income (ttm): 45.1B
EPS (ttm): ₹44.9
P/E (trailing): 26.2x
P/E (forward): 27.5x
Market cap: 1.2T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E27.5

P25 n/aP50 n/aP75 n/a

Trailing P/E26.2

P25 n/aP50 n/aP75 n/a

ROE18.3

P25 n/aP50 n/aP75 n/a

ROIC10.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NSE/ZYDUSLIFE indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

INR

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-04
Employees	29,980
Employees change	2,063
Employees growth	7.39%
Enterprise value	INR 1.3T
Exchange	National Stock Exchange of India
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1952
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	INE010B01027
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split date	2015-10-06
Last stock split type	Forward
Market cap	INR 1.2T
Next earnings date	2026-11-04
Price	INR 1,175.50
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	nse/ZYDUSLIFE
Website	https://zyduslife.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	23.97x
Average P/E ratio (10Y)	22.42x
Average P/E ratio (3Y)	22.2x
Average P/E ratio (5Y)	19.72x
Earnings yield	3.82%
EV/Earnings	28.2x
EV/EBIT	23.35x
EV/EBITDA	18.34x
EV/Sales	4.45x
FCF / EV yield	-1%
FCF yield	-1.09%
Forward P/E	27.53x
Graham number	521.49432
Graham upside	-55.64%
Industry forward P/E	33.34x
Industry P/E	39.18x
Lynch fair value	INR 662.38
Lynch upside	-43.65%
P/B ratio	3.96x
P/E ratio	26.2x
P/OCF ratio	55.4x
P/S ratio	4.1x
PEG ratio	9.66x
Price / tangible book value	12.08x
Price/EBITDA ratio	17.23x
Sector forward P/E	36.5x
Sector P/E	46.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	18.71%
EBITDA margin	23.81%
Effective tax rate	24.8%
Gross margin	72.11%
Operating margin	18.71%
Pretax margin	21.36%
Profit margin	15.78%
Profit per employee	INR 1.5M
Profitable quarters	60
Profitable years	23
Revenue per employee	INR 9.5M
ROA	8.13%
ROA (5Y)	8.46%
ROCE	15.87%
ROE	18.32%
ROE (5Y)	16.26%
ROIC	10.84%
ROIC (5Y)	14.9%
Tax / revenue	5.3%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-1.28%
EPS growth (Q)	-35.87%
EPS growth (QoQ)	-26.09%
EPS growth 10Y	12.47%
EPS growth 3Y	21.56%
EPS growth 5Y	15.16%
EPS growth years	3
Gross profit growth	22.25%
Gross profit growth (Q)	20.76%
Gross profit growth 3Y	20.52%
Gross profit growth 5Y	15.43%
Net income growth	-1.3%
Net income growth (Q)	-35.93%
Net income growth (QoQ)	-26.15%
Net income growth 3Y	21.3%
Net income growth 5Y	14.77%
Net income growth years	3
OCF growth	-68.79%
OCF growth 10Y	1.12%
OCF growth 3Y	-7.67%
OCF growth 5Y	-8.47%
Operating income growth	-8.71%
Operating income growth (Q)	-26.52%
Operating income growth 3Y	13.47%
Operating income growth 5Y	14.18%
Revenue growth	21.11%
Revenue growth (Q)	21.96%
Revenue growth (QoQ)	5.67%
Revenue growth 10Y	11.39%
Revenue growth 3Y	15.8%
Revenue growth 5Y	12.86%
Revenue growth quarters	17
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -33.9B
Depreciation and amortization	INR 14.6B
EBIT	INR 53.5B
EBITDA	INR 68.1B
EPS	INR 44.86
FCF per share	INR -12.81
Financing cash flow	INR 58.1B
Free cash flow	INR -12.8B
Gross profit	INR 206.2B
Income taxes	INR 15.1B
Investing cash flow	INR -83B
Net borrowing	INR 72.7B
Net cash flow	INR 284M
Net income	INR 45.1B
Operating income	INR 53.5B
Revenue	INR 285.9B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 269.43
Debt / EBITDA	1.83
Debt / equity	0.42
Interest coverage	12.26
Net cash (debt)	INR -75.4B
Net cash / market cap	-6.43%
Net debt / EBITDA	1.11
Net debt / equity	0.26
Piotroski F-Score	4
Shareholders' equity	INR 295.8B
Tangible book value	INR 97B
Tangible book value per share	INR 96.43
Total cash	INR 49.7B
Total debt	INR 125.1B
WACC	5.94%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.61
Current ratio	1.27
Inventory turnover	1.57
Quick ratio	0.67
Working capital	INR 41.9B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.02%
Dividend growth	-90.91%
Dividend growth (10Y)	-15.83%
Dividend growth (3Y)	-44.97%
Dividend growth (5Y)	-22.16%
Dividend growth years	1
Dividend payment date	2026-09-10
Dividend payment years	26
Dividend payout frequency	Annual
Dividend per share	INR 1.00
Dividend yield	0.09%
Ex-dividend date	2026-07-24
Last dividend	INR 1.00
Payout ratio	2.23%
Shareholder yield	0.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	197.52%
10Y return CAGR	12.43%
10Y total return	222.65%
150-day SMA	INR 1,072.70
15Y price change	673.71%
15Y return CAGR	15.56%
15Y total return	775.68%
1D price change	0.22%
1M price change	-2.36%
1M total return	-2.36%
1W price change	5.53%
1W total return	5.53%
1Y price change	15.94%
1Y return CAGR	16.06%
1Y total return	16.05%
20-day SMA	INR 1,142.42
200-day SMA	INR 1,029.89
20Y price change	2,524.7%
20Y return CAGR	18.79%
20Y total return	3,027.77%
3M price change	6.07%
3M total return	6.07%
3Y price change	104.42%
3Y return CAGR	27.53%
3Y total return	107.46%
50-day SMA	INR 1,143.87
50-day SMA vs 200-day SMA	50over200
52-week high	INR 1,232.10
52-week high date	2026-09-29
52-week low	INR 835.50
52-week low date	2026-04-02
5Y price change	130.85%
5Y return CAGR	18.96%
5Y total return	138.17%
6M price change	25.1%
6M total return	25.21%
All-time high	INR 1,324.30
All-time high date	2024-08-09
All-time low	INR 5.53
All-time low date	2001-07-25
Average true range (ATR)	INR 32.36
Average volume	1.4M
Beta (1Y)	0.26
Beta (2Y)	0.31
Beta (5Y)	0.37
Change from 52-week high	-4.59%
Change from 52-week low	40.69%
Change from all-time high	-11.24%
Change from all-time low	21,145.26%
Change from open	0.73%
Day's gap	-0.5%
Dollar volume	INR 701.5M
High price	INR 1,184.00
Low price	INR 1,155.90
Monthly RSI	69.47
Open price	INR 1,167.00
Position in 52-week range	69.75%
Previous close	INR 1,172.90
Price vs 150-day SMA	9.58%
Price vs 20-day SMA	2.9%
Price vs 200-day SMA	14.14%
Price vs 50-day SMA	2.77%
Relative volume	0.42
RSI	58.62
Sharpe ratio	0.63
Sharpe ratio (3Y)	0.87
Sharpe ratio (5Y)	0.6
Sortino ratio	1.23
Sortino ratio (3Y)	1.53
Sortino ratio (5Y)	1.14
Volume	596.8K
Weekly RSI	60.27
YTD price change	28.56%
YTD total return	28.68%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	240.8M
Shares change (QoQ)	-0.08%
Shares change (YoY)	-0.02%
Shares held by insiders	75.68%
Shares held by institutions	17.56%
Shares outstanding	997.5M

Deeper analysis on NSE/ZYDUSLIFE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NSE/ZYDUSLIFE report

Is a complete NSE/ZYDUSLIFE research report available?

No complete published report is available for nse/ZYDUSLIFE (NSE/ZYDUSLIFE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NSE/ZYDUSLIFE (NSE/ZYDUSLIFE)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/ZYDUSLIFE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/ZYDUSLIFE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NSE/ZYDUSLIFE

Frequently asked questions